Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 16 of 13268 for:    "Heart Diseases"

The Prevalence of Rheumatic Heart Disease in School Children in Fiji

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2008 by Queensland Institute of Medical Research.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
Menzies School of Health Research
University of Melbourne
Information provided by:
Queensland Institute of Medical Research
ClinicalTrials.gov Identifier:
NCT00779662
First received: October 23, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
  Purpose
This study is an epidemiological observational cross-sectional study designed to estimate the prevalence of echocardiographically confirmed RHD in school children from 5-14 years of age in Fiji. The study will be conducted in the Central Division of Fiji within a selection of up to16 primary schools located in the Korovou/Tailevu and Rewa/Nausori sub-divisions. School children will be enrolled after informed consent has been obtained. A standard cardiac examination (auscultation) will be performed as part of the routine annual health check by both school nurses, who have attended a training workshop, and by a paediatrician. All children with or without murmur will have a screening echocardiogram performed at a subsequent visit. Children found to have possible, probable or definite RHD or other cardiac pathology on the screening echocardiogram, will have a full echocardiogram performed by the echocardiography technician at the time of the second study visit. They will all also be referred to a paediatric cardiologist for further investigation and management and monitoring . Cases of RHD will be referred to and followed up by the National Fiji RHD register based at CWMH in Suva.

Condition
Rheumatic Heart Disease

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: The Prevalence of Rheumatic Heart Disease in School Children in Fiji

Resource links provided by NLM:


Further study details as provided by Queensland Institute of Medical Research:

Estimated Enrollment: 2000
Study Start Date: February 2008
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   5 Years to 14 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The study will be conducted in the Central Division of Fiji within a selection of up to16 primary schools located in the Korovou/Tailevu and Rewa/Nausori sub-divisions.
Criteria

Inclusion Criteria:

  • Informed consent will be obtained for all participants
  • All children between the ages of 5-14 Years are eligible for the study.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Samantha Colquhoun, Menzies School of Health Research
ClinicalTrials.gov Identifier: NCT00779662     History of Changes
Other Study ID Numbers: 07- 0070  U01AI060579 
Study First Received: October 23, 2008
Last Updated: October 23, 2008
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Queensland Institute of Medical Research:
Rheumatic Heart Disease
Streptococcus
Fiji

Additional relevant MeSH terms:
Heart Diseases
Rheumatic Diseases
Rheumatic Heart Disease
Cardiovascular Diseases
Musculoskeletal Diseases
Connective Tissue Diseases
Rheumatic Fever
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on December 09, 2016